SMS Pharmaceuticals rose 1.79% to Rs 221.80 after company announced that it has successfully completed a US Food and Drug Administration (USFDA) inspection at its API manufacturing facility located in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback